NCT05921942View on ClinicalTrials.gov

The Impact of Metformin Administration on the Clinical Outcome of Stage IV Colon Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

April 15, 2020

Primary Completion Date

December 30, 2022

Study Completion Date

December 30, 2022

Conditions
Colorectal Cancer
Interventions
DRUG

Metformin

500 mg twice daily or 1000 mg once daily

Trial Locations (1)

11314

Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT05921942 - The Impact of Metformin Administration on the Clinical Outcome of Stage IV Colon Cancer | Biotech Hunter | Biotech Hunter